Murray Jason Hulse
Co-Founder, CEO & Chairman
Murray Jason Hulse has filed 12 SEC Form 4 filings (43 transaction rows) across 1 company, with disclosures dating back to 2025. 12 of those filings fall inside the rolling window. Most recent filing: Oct 21, 2026.
On the most recent filing, Murray Jason Hulse is listed as Co-Founder, CEO & Chairman at PACS Group, Inc. Inside the rolling window, Murray Jason Hulse reported no open-market purchases and 25 open-market sales totaling $35.9M in PACS. The largest disclosed transaction in the window is a sale of 110,035 PACS shares on Oct 15, 2026, worth $5.2M.
Companies traded
Other insiders at PACS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$35.9M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| PACS | Co-Founder, CEO & Chairman | Sale | 1,620 | $77K | Oct 21 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 37,477 | $1.8M | Oct 21 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 6,610 | $315K | Oct 21 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 232 | $10K | Oct 16 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 110,035 | $5.2M | Oct 16 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 8,462 | $403K | Oct 16 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 35,975 | $1.6M | Oct 7 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 717 | $30K | Oct 7 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 33,032 | $1.4M | Oct 5 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 26,052 | $1.1M | Oct 5 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 24,224 | $1.0M | Oct 5 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 8,771 | $396K | Sep 14 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 10,529 | $476K | Sep 14 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 317 | $14K | Sep 14 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 23,072 | $985K | Sep 9 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 24,057 | $1.0M | Sep 9 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 4,758 | $206K | Sep 9 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 24,157 | $1.0M | Sep 4 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 23,783 | $1.0M | Sep 4 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 20,173 | $858K | Sep 4 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 91,306 | $4.0M | Aug 24 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 59,244 | $2.6M | Aug 24 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 84,602 | $3.7M | Aug 20 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 66,797 | $3.0M | Aug 20 | SEC ↗ | |
| PACS | Co-Founder, CEO & Chairman | Sale | 84,717 | $3.7M | Aug 20 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Murray Jason Hulse made?
Murray Jason Hulse has filed 12 SEC Form 4 filings (43 transaction rows) across 1 company since 2025.
Which companies does Murray Jason Hulse trade?
Murray Jason Hulse has filed SEC Form 4 disclosures for 1 company, including PACS.
When was Murray Jason Hulse's most recent SEC Form 4 filing?
Murray Jason Hulse's most recent SEC Form 4 filing on Tracefour is dated Oct 21, 2026.
What is Murray Jason Hulse's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Murray Jason Hulse is listed as Co-Founder, CEO & Chairman.
What is Murray Jason Hulse's total buy and sell value in the current window?
Inside the rolling retention window, Murray Jason Hulse bought $0 and sold $35.9M based on SEC Form 4 filings.
What was Murray Jason Hulse's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 110,035 PACS shares on 2026-10-15, worth $5.2M, per SEC Form 4 filings.